The Medicare reimbursement rate for HCPCS Q5121 is around $23.24 per 10 mg injection in 2025, with variations depending on region and payer contracts
The same product can be purchased for just $137 in Germany and $92 in the United Kingdom
Tirzepatide targets both the GLP 1 and the GIP receptor agonist, while semaglutide mimics only the GLP-1 receptor agonist, a type of hormone in the body that impacts everything from the brain to muscle to the pancreas, stomach and liver
These medications are all injections except for Rybelsus which is an oral tablet
Safety Monitoring, Side Effects, and When to Adjust Treatment Common semaglutide side effects include nausea, vomiting, constipation, and diarrheatypically dose-dependent and transient
Or if needed, inform them to reinitiate Wegovy pen and follow the dose-escalation schedule, which may reduce the occurrence of GI symptoms associated with reinitiation of treatment